From: Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial
Dependent variables | Group (n) | Week 0 (M ± SD) | Week 1 (M ± SD) | Week 5 (M ± SD) | Difference (w1–w0) | Z (p)a | Difference (w5–w0) | Z (p)a | Difference (w5–w1) | Z (p)a |
---|---|---|---|---|---|---|---|---|---|---|
VAS of pain | DS (n = 11) | 50.91 ± 18.14 | 30.91 ± 22.56 | 8.45 ± 5.65 | −20.00 ± 27.93 | − 0.71 (0.479) | − 42.45 ± 18.38 | − 1.54 (0.123) | − 22.45 ± 19.54 | − 3.03 (0.002) |
Placebo (n = 12) | 44.17 ± 11.65 | 16.00 ± 15.47 | 15.00 ± 15.08 | − 28.17 ± 9.93 | −29.17 ± 13.11 | −1.00 ± 11.65 | ||||
Degree of edema | DS (n = 11) | 1.36 ± 1.03 | 0.27 ± 0.47 | 0.36 ± 0.50 | − 0.95 ± 1.10 | − 1.31 (0.189) | − 0.98 ± 0.83 | − 0.85 (0.396) | 0.03 ± 0.51 | − 0.72 (0.473) |
Placebo (n = 12) | 1.08 ± 0.79 | 0.50 ± 0.67 | 0.25 ± 0.62 | − 0.41 ± 0.67 | − 0.68 ± 0.86 | −0.28 ± 0.81 | ||||
TOTAL EQ-5D-5L | DS (n = 11) | 11.73 ± 3.72 | 9.73 ± 3.35 | 5.82 ± 0.75 | − 2.00 ± 3.49 | − 0.88 (0.880) | − 5.91 ± 3.59 | − 1.85 (0.065) | − 3.91 ± 2.88 | − 2.66 (0.008) |
Placebo (n = 12) | 9.67 ± 2.31 | 7.50 ± 2.15 | 6.17 ± 1.40 | − 2.17 ± 1.40 | − 3.50 ± 1.68 | −1.33 ± 1.61 | ||||
TOTAL FAOS | DS (n = 11) | 261.77 ± 79.97 | 341.45 ± 88.16 | 459.39 ± 40.28 | 79.67 ± 88.48 | − 0.31 (0.758) | 197.62 ± 71.97 | − 1.23 (0.218) | 117.95 ± 62.34 | − 2.59 (0.010) |
Placebo (n = 12) | 286.15 ± 64.35 | 389.86 ± 72.46 | 443.85 ± 52.68 | 103.71 ± 60.16 | 157.70 ± 49.73 | 53.99 ± 46.46 | ||||
FAOS ache | DS (n = 11) | 52.00 ± 15.63 | 69.69 ± 14.41 | 95.19 ± 5.28 | 17.68 ± 14.67 | − 1.05 (0.294) | 43.18 ± 14.36 | − 2.35 (0.019) | 25.50 ± 11.79 | − 3.49 (< 0.001) |
Placebo (n = 12) | 59.67 ± 11.50 | 82.63 ± 16.29 | 89.35 ± 10.51 | 22.92 ± 14.08 | 29.64 ± 9.29 | 6.73 ± 8.16 |